Glatiramer Acetate
7 NDCs across 4 manufacturers|5 Generic,2 Brand
Glatiramer Acetate is used to treat relapsing-remitting multiple sclerosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 20, 1996, and the first generic was approved Apr 16, 2015. In 2024, Medicare Part D spent $412 million on Glatiramer Acetate across 107,000 claims for 14,000 beneficiaries.
Glatiramer Acetate is available as 7 NDCs from 4 manufacturers (5 generic, 2 brand), with NADAC prices from $41.76 to $541.12 per ML — the most expensive product costs about 13× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
7
5G / 2B
Manufacturers
4
competing in market
Price Spread
$41.76 – $541.12
per ML
7d Activity
avg -2.9% WoW · of 7 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Teva Neuroscience, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
4 manufacturers producing GLATIRAMER ACETATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
COPAXONE 40 MG/ML SYRINGE | $541.1156 per ML | +0.08% |
COPAXONE 20 MG/ML SYRINGE | $229.7988 per ML | — |
GLATIRAMER 40 MG/ML SYRINGE | $86.0952 per ML | -5.47% |
GLATOPA 40 MG/ML SYRINGE | $86.0952 per ML | -5.47% |
GLATIRAMER 20 MG/ML SYRINGE | $41.7570 per ML | -2.17% |
GLATOPA 20 MG/ML SYRINGE | $41.7570 per ML | -2.17% |
GLATIRAMER 20 MG/ML SYRINGE | $41.7570 per ML | -2.17% |
Frequently Asked Questions
What is Glatiramer Acetate used to treat?
Glatiramer Acetate is used to treat relapsing-remitting multiple sclerosis, per the National Library of Medicine's MED-RT classification.
When did Glatiramer Acetate become available as a generic?
FDA approved the first generic Glatiramer Acetate (ANDA) on Apr 16, 2015.
How much does Medicare spend on Glatiramer Acetate?
In 2024, Medicare Part D spent $412 million on Glatiramer Acetate across 107,000 claims for 14,000 beneficiaries.
How many Glatiramer Acetate products are on the market?
The Glatiramer Acetate drug market contains 7 NDCs from 4 manufacturers — 5 generic and 2 brand products.
What is the price range for Glatiramer Acetate?
NADAC reference prices for Glatiramer Acetate range from $41.7570 to $541.1156 per ML — the most expensive product costs about 13× the cheapest.
Is generic Glatiramer Acetate cheaper than brand?
The average generic NADAC for Glatiramer Acetate is $59.4923 per ML, versus $385.4572 for brand-labeled products — brand versions average about 6.5× the generic price.
Which manufacturers make Glatiramer Acetate?
4 manufacturers list Glatiramer Acetate in NADAC. Ranked by number of NDCs, the largest are Teva Neuroscience, Inc. (2), Sun Pharmaceutical Industries Inc. (2), Sandoz Inc. (2), Mylan Pharmaceuticals Inc. (1).
How has the price of Glatiramer Acetate changed recently?
Over the past 7 days, 1 Glatiramer Acetate NDC rose and 5 fell, with a market-wide average change of -2.9%.